Peptidetesting

Back to the glossary

General

Active substance

An active substance, also called an Active Pharmaceutical Ingredient (API), is the chemical molecule in a drug or research chemical that is intended to produce a biological effect. Laboratory testing checks its identity, purity, and exact content.

Also called: Active Pharmaceutical Ingredient, API, drug substance

An active substance is the core chemical molecule, such as a specific peptide sequence, intended to provide pharmacological activity in diagnosing, treating, or preventing disease. Laboratory evaluation of an active substance looks beyond a single purity number, assessing distinct parameters like identity, purity, and content to ensure a complete analytical result.

Laboratory parameters for an active substance

  • Identity confirms that the tested material is the correct molecule.
  • Purity compares the target molecule with impurities.
  • Content or assay quantifies the absolute amount present.

Interpretation risks in lab reports and CoAs

When reading a lab report or Certificate of Analysis (CoA), the primary risk is that results depend on the analytical method used, such as HPLC or quantitative NMR. A single purity percentage does not capture the full picture. A credible report names the specific methods applied and identifies individual impurities. Structural properties like aggregation states also matter, as changes can affect biological activity.

A frequent confusion is the difference between an active substance and a drug product. The active substance is the core molecule, while a drug product is the finished formulation containing the active substance mixed with inactive ingredients. Purity, the proportion of the target molecule, is distinct from content or assay, which quantifies the absolute amount present. Substances sold as unregulated research chemicals are not automatically verified against pharmaceutical standards unless the seller provides a compliant CoA from an accredited lab.

Sources

  1. Guideline on Summary of requirements for active substances in the quality part of the dossier
  2. Guideline on the chemistry of active substances
  3. Chemistry of active substances (chemistry of new active substances) - Scientific guideline | European Medicines Agency (EMA)
  4. Guideline on the chemistry of active substances | EMA
  5. Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control - PMC
  6. Q7A Good Manufacturing Practice Guidance for Active ...
  7. ICH Q6B Specifications: test procedures and acceptance criteria for biotechnological/biological products - Scientific guideline | European Medicines Agency (EMA)
  8. Q6B Specifications: Test Procedures and Acceptance ...
  9. Importance of Purity Evaluation and the Potential of Quantitative 1 H NMR as a Purity Assay
  10. [PDF] Guidance for Industry- Synthetic Peptides - FDA
  11. [PDF] Guideline on the chemistry of new active substances | EMA
  12. SURVEY OF PEPTIDE QUANTIFICATION METHODS AND COMPARISON OF THEIR REPRODUCIBILITY: A CASE STUDY USING OXYTOCIN - PMC
  13. Q 6 B Specifications: Test Procedures and Acceptance Criteria ...
  14. Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
  15. Endogenous ethanol 'auto-brewery syndrome' as a drunk-driving defence challenge
  16. N-Nitrosodimethylamine as an Emerging Environmental Contaminant: Sources, Analytical Advances, and Ecotoxicological and Human Health Risks
  17. Research Progress in Current and Emerging Issues of PFASs' Global Impact: Long-Term Health Effects and Governance of Food Systems